Identifying Drug-Resistant Mutants in Malaria
Author Information
Author(s): Tipsuwan Wachiraporn, Srichairatanakool Somdet, Kamchonwongpaisan Sumalee, Yuthavong Yongyuth, Uthaipibull Chairat
Primary Institution: National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), Thailand
Hypothesis
Can a transgenic Plasmodium berghei model be used to predict drug-resistant mutations in Plasmodium falciparum?
Conclusion
The study successfully demonstrated that the transgenic P. berghei system can predict drug-resistant mutations in an in vivo setting.
Supporting Evidence
- The S108N mutation was identified as a key resistance mutation.
- Transgenic P. berghei parasites showed normal growth rates compared to non-transgenic parasites.
- The system can be used to identify novel drug-resistant mutants against new antifolate compounds.
Takeaway
Scientists created a special type of malaria parasite to help find out how some parasites become resistant to medicine. This can help in making better medicines.
Methodology
The study used error-prone PCR to create mutant libraries of the Pfdhfr gene, which were then transfected into P. berghei to select for drug-resistant mutants.
Limitations
The study primarily focused on one specific mutation (S108N) and may not account for other mutations that contribute to drug resistance.
Participant Demographics
Female BALB/c mice, aged 4-6 weeks, weighing 20-25 g.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website